These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36619145)

  • 21. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
    Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
    Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life.
    Graff LA; Fowler S; Jones JL; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Targownik LE; Windsor JW; Bernstein CN
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S46-S53. PubMed ID: 34755039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology and the pathogenesis of inflammatory bowel disease.
    Karlinger K; Györke T; Makö E; Mester A; Tarján Z
    Eur J Radiol; 2000 Sep; 35(3):154-67. PubMed ID: 11000558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD.
    Kaplan GG; Kuenzig ME; Windsor JW; Bernstein CN; Bitton A; Coward S; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Ghandeharian S; Rohatinsky N; Weinstein J; Jones May T; Browne M; Jannati N; Tabatabavakili S; Im JHB; Meka S; Vukovic S; Davis T; Goddard Q; Gorospe J; Stocks T; Caplan L; Kanaan N; Stuart D; Ramsay T; Robinson KJ; Charron-Bishop D; Benchimol EI
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S76-S82. PubMed ID: 37674494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice.
    Chen Y; Yu Q; Farraye FA; Kochhar GS; Bernstein CN; Navaneethan U; Wu K; Zhong J; Schwartz DA; Wu H; Zheng JJ; Iacucci M; Kiran RP; Shen B
    Intest Res; 2021 Jul; 19(3):332-340. PubMed ID: 32475088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
    Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
    Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and the risk factors for the exacerbation of symptoms in patients with inflammatory bowel disease during the COVID-19 pandemic.
    Wu J; Fang Y; Bai B; Wu Y; Liu Q; Hu J; Hu N; Mei Q; Han W
    Front Med (Lausanne); 2024; 11():1404880. PubMed ID: 38903816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
    Classen JM; Muzalyova A; Nagl S; Fleischmann C; Ebigbo A; Römmele C; Messmann H; Schnoy E
    Dig Dis; 2022; 40(6):719-727. PubMed ID: 34915480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation.
    Lev-Tzion R; Focht G; Lujan R; Mendelovici A; Friss C; Greenfeld S; Kariv R; Ben-Tov A; Matz E; Nevo D; Barak-Corren Y; Dotan I; Turner D
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1263-e1282. PubMed ID: 34954338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Goodsall TM; Han S; Bryant RV
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1550-1555. PubMed ID: 33063927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology and risk factors of inflammatory bowel disease.
    Ye Y; Pang Z; Chen W; Ju S; Zhou C
    Int J Clin Exp Med; 2015; 8(12):22529-42. PubMed ID: 26885239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD.
    Roy S; Sheikh SZ; Furey TS
    Sci Rep; 2021 Aug; 11(1):16522. PubMed ID: 34389789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Patient-Prioritized Agenda for Information Needs During the COVID-19 Pandemic: A Qualitative Study of Patients With Inflammatory Bowel Disease.
    Long MD; Grewe ME; Cerciello E; Weisbein L; Catabay K; Kappelman MD
    Crohns Colitis 360; 2021 Oct; 3(4):otab066. PubMed ID: 34805986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal lithiasis and inflammatory bowel diseases, an update on pediatric population.
    Bianchi L; Gaiani F; Bizzarri B; Minelli R; Cortegoso Valdivia P; Leandro G; Di Mario F; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):76-80. PubMed ID: 30561398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey.
    Martin Arranz E; Suarez Ferrer C; García Ramírez L; Rueda García JL; Sánchez-Azofra M; Poza Cordón J; Noci J; Zabana Y; Barreiro-de Acosta M; Martín-Arranz MD
    Inflamm Bowel Dis; 2020 Jul; 26(8):1149-1154. PubMed ID: 32495826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.
    Nguyen GC; Targownik LE; Singh H; Benchimol EI; Bitton A; Murthy SK; Bernstein CN; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S68-S72. PubMed ID: 31294386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.